We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
In light of ACM Biolabs's recent breakthrough and the efficacy of its COVID-19 vaccine against delta and #omicron variants, we interviewed Alexander Breidenbach, its Chief Development Officer on the overall challenges and intricacies of vaccine research and its role in preventing infectious diseases.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
